Bosentan ameliorates hypertension in rats exposed to chronic intermittent hypoxia through inhibiting renal sympathetic nerve activity.
- Author:
Sheng-Chang YANG
1
;
Ya-Jing GUO
2
;
Fu-Yang YU
1
;
Ling-Ling CHEN
3
;
Wen-Ya LI
1
;
En-Sheng JI
4
Author Information
1. Department of Physiology, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
2. Scientific Research Center, Hebei University of Chinese Medicine, Shijiazhuang 050200, China.
3. Department of Pharmacy, Xixi Hospital of Hangzhou, Hangzhou 310012, China.
4. Department of Physiology, Hebei University of Chinese Medicine, Shijiazhuang 050200, China. jesphy@126.com.
- Publication Type:Journal Article
- From:
Acta Physiologica Sinica
2018;70(4):354-360
- CountryChina
- Language:Chinese
-
Abstract:
The purpose of this study is to investigate the effect of the oral endothelin antagonist Bosentan on blood pressure and renal sympathetic nerve activity (RSNA) in rats exposed to chronic intermittent hypoxia (CIH), and to explore the sympathoexcitation mechanism of endothelin-1 (ET-1) in CIH-induced hypertension. Twenty-four male SD rats were randomly divided into normoxia, CIH and Bosentan groups. Rats in the normoxia group were exposed to normoxic environment, and rats in CIH or Bosentan group were exposed to intermittent hypoxia for 3 weeks. Bosentan was given at 50 mg/kg by intragastric administration before intermittent hypoxia exposure in Bosentan group. Systolic blood pressure (SBP) was measured by BP-2000, and the change of RSNA to sodium nitroprusside (SNP) or phenylephrine (PE) was recorded by PowerLab signal acquisition system. Serums of all rats were collected and the contents of ET-1 and norepinephrine (NE) were measured by ELISA. Results showed that blood pressure was gradually increased following CIH exposure compared with the normoxia group during the 3 weeks (P < 0.01, P < 0.01, P < 0.001). The basal RSNA was increased and baroreflex sensitivity was decreased in rats exposed to CIH. Furthermore, the blood pressure was positively correlated with the level of ET-1 in serum in rats exposed to CIH (r = 0.833, P = 0.01). Bosentan administration significantly decreased SBP and basal RSNA, increased the baroreflex sensitivity, and decreased serum NE level in rats exposed to CIH. These results suggest that ET-1 is related with blood pressure elevation in rats exposed to CIH, and Bosentan reverses CIH-induced hypertension by decreasing RSNA.
